Astellas Pharma Global Development, Inc.

This study looks at the long-term safety of an eye injection called avacincaptad pegol for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. It includes 278 adults aged 50 and older who already completed a previous study …

This study tested a new drug, gilteritinib, combined with a standard medicine (azacitidine) in 183 adults newly diagnosed with acute myeloid leukemia (AML) who have a specific gene change (FLT3 mutation) and cannot receive intensive chemotherapy. The goal was to see if the combin…

This study tested an experimental drug called Zimura in 121 people with Stargardt disease, a genetic condition that causes progressive vision loss. Participants received either Zimura injections or a sham procedure. The goal was to see if the drug could safely slow damage to the …

This study tested a new drug called gilteritinib against standard chemotherapy in 371 people with a specific type of acute myeloid leukemia (AML) that has a FLT3 mutation and had come back or not responded to initial treatment. The goal was to see if gilteritinib helps people liv…

This study tested whether adding enzalutamide to standard hormone therapy (ADT) helps men with prostate cancer that has spread to other parts of the body. About 1,150 men took part. The goal was to see if the combination delayed cancer growth or death better than ADT alone. Resul…

This study tested a new drug called enfortumab vedotin against standard chemotherapy in 608 adults with advanced bladder or urinary tract cancer that had worsened after prior treatment. The goal was to see if the new drug helped people live longer and slowed cancer growth. Result…

This study tested a new medicine called ASKP1240 in 149 people who received a new kidney. The goal was to see if it could help prevent the body from rejecting the new kidney. The study compared different combinations of drugs to find a safer and more effective way to protect the …

This study tested a new dye called ASP5354 that makes the ureter glow under a special camera during abdominal surgery. The goal was to help surgeons see the ureter more clearly and avoid accidentally injuring it. The study included 107 people aged 12 and older with normal or redu…

This study tested a new dye called ASP5354 that makes the ureter (the tube from kidney to bladder) glow under a special camera during abdominal surgery. 95 adults having abdominal surgery received the dye, and surgeons compared how well they could see the ureter with normal light…

This study tested an experimental drug called ASP8062 to see if it could reduce pain in people with fibromyalgia. A total of 183 adults took either the drug or a placebo for 8 weeks. Researchers measured changes in daily pain scores and monitored for side effects to determine if …

This study tested a medicine called fezolinetant to see if it can safely reduce hot flashes and night sweats in Chinese women going through menopause. About 150 women took either the medicine or a placebo (dummy pill) once a day for 12 weeks. The goal was to see if the medicine h…

This study tested a new drug called ASKP1240 in 60 people with moderate to severe plaque psoriasis. The goal was to see if the drug is safe and how it works in the body compared to a placebo. Participants received multiple doses, and researchers measured drug levels, immune syste…